MENU
EXEL Exelixis Chart, History Price & Graph
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
EXEL and Stocks
Correlation & Price change
A.I.dvisor tells us that EXEL and CPRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXEL and CPRX's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EXEL | 1D Price Change % | ||
|---|---|---|---|---|
| EXEL | 100% | -0.77% | ||
| CPRX - EXEL | 32% Poorly correlated | -2.52% | ||
| RVMD - EXEL | 31% Poorly correlated | -2.51% | ||
| HALO - EXEL | 30% Poorly correlated | -4.12% | ||
| RIGL - EXEL | 29% Poorly correlated | -2.38% | ||
| ALGS - EXEL | 27% Poorly correlated | -5.60% | ||
More | ||||
Groups containing EXEL
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EXEL | 1D Price Change % |
|---|---|---|
| EXEL | 100% | -0.77% |
| drugs theme (265 stocks) | 30% Poorly correlated | +5.37% |
| cancer theme (87 stocks) | 28% Poorly correlated | +0.89% |
| biotechnology theme (248 stocks) | 28% Poorly correlated | +5.56% |
| modules theme (9 stocks) | 28% Poorly correlated | +1.12% |
| treatment theme (61 stocks) | 24% Poorly correlated | +0.91% |